Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hong In Tong Golden Bile Liver Care Capsules in Adults With Abnormal Liver Function and Blood Lipids
ChiCTR2600126190Phase 4Not yet recruiting
- Sponsor
- Guangzhou Eighth People's Hospital
- Start
- Jun 2026
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Hong In Tong Golden Bile Liver Care Capsules in dyslipidemia, sponsored by Guangzhou Eighth People's Hospital. Primary endpoints: Serum aminotransferases (AST, ALT, GGT) and Adverse events. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
Hong In Tong Golden Bile Liver Care Capsules
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on ChiCTR2600126190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600126190.